FAPI-04 PET/CT Using [18F]AlF Labeling Strategy: Automatic Synthesis, Quality Control, and In Vivo Assessment in Patient

FAPI-04 PET/CT Using [18F]AlF Labeling Strategy: Automatic Synthesis, Quality Control, and In Vivo Assessment in Patient

68Ga labeled FAPI is the current standard for FAPI-PET, but its batch activity is limited. [18F]AlF-NOTA-FAPI-04 is a promising alternative combining the advantages of a chelator-based radiolabeling method with the unique properties of fluorine-18. The objective of this study was to develop a quick...

Full description

Bibliographic Details
Main Authors: Xiao Jiang, Xiaoxiong Wang, Taipeng Shen, Yutang Yao, Meihua Chen, Zeng Li, Xiuli Li, Jiaqi Shen, Ying Kou, Shirong Chen, Xing Zhou, Zhifu Luo, Zhuzhong Cheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Oncology
Subjects:
fibroblast activation protein inhibitor (FAPI)-PET
fibroblast activation protein inhibitor
automatic synthesis
PET molecular imaging
cancer associated fibroblasts
invasive ductal carcinoma
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.649148/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.649148/full

Similar Items